SCHEMBL14876929

SCHEMBL14876929

CC[N+](CC)(CC)CCNc1ccc(NCC[N+](CC)(CC)CC)c2c1C(=O)c1ccccc1C2=O

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 4/20 0.55
▸ KMT2A Q03164 4/20 0.55
▸ POLB P06746 4/20 0.55
▸ BLM P54132 3/20 0.55
▸ NSD2 O96028 2/20 0.55
▸ RXFP1 Q9HBX9 1/20 0.55
▸ TOP2B Q02880 1/20 0.54
▸ RAB9A P51151 2/20 0.51
▸ NPC1 O15118 1/20 0.51
▸ MTOR P42345 1/20 0.51
▸ SIRT2 Q8IXJ6 1/20 0.51
▸ TERT O14746 4/20 0.49
▸ MAPT P10636 5/20 0.42
▸ MAPK1 P28482 3/20 0.42
▸ L3MBTL1 Q9Y468 3/20 0.42
▸ LMNA P02545 3/20 0.42
▸ TDP1 Q9NUW8 3/20 0.42
▸ RECQL P46063 2/20 0.42
▸ USP2 O75604 2/20 0.42
▸ GAA P10253 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14876751 0.90 MAPT (0.54) MEN1KMT2APOLBBLMNSD2
SCHEMBL2552095 0.88 NSD2 (0.51) MEN1KMT2APOLBBLMNSD2
SCHEMBL20334211 0.86 TERT (0.61) MEN1KMT2APOLBBLMNSD2
SCHEMBL9369093 0.85 MEN1 (0.52) MEN1KMT2APOLBBLMNSD2
SCHEMBL14876242 0.84 TERT (0.58) MEN1KMT2APOLBBLMNSD2
SCHEMBL14876259 0.83 TERT (0.50) MEN1KMT2APOLBBLMNSD2
SCHEMBL29940221 0.82 POLB (0.63) MEN1KMT2APOLBBLMNSD2
SCHEMBL11131632 0.82 POLB (0.63) MEN1KMT2APOLBBLMNSD2
SCHEMBL20333860 0.81 MEN1 (0.51) MEN1KMT2APOLBBLMNSD2
SCHEMBL14876578 0.80 CYP19A1 (0.59) MEN1KMT2APOLBBLMNSD2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11255761-B2 Method of analysing a cell or other biological material containing a nucleic acid BIOSTATUS LIMITED (GB) 2022-02-22 — — US disclosed
US-20150268142-A1 METHOD OF ANALYSING A CELL OR OTHER BIOLOGICAL MATERIAL CONTAINING A NUCLEIC ACID BIOSTATUS LIMITED (GB) 2015-09-24 — — US disclosed
US-9051467-B2 Method of analysing a cell or other biological material containing a nucleic acid BIOSTATUS LIMITED (GB) 2015-06-09 — — US disclosed
US-20130101994-A1 Method of Analysing a Cell or Other Biological Material Containing a Nucleic Acid BIOSTATUS LIMITED (GB) 2013-04-25 — — US disclosed
Send feedback